Recruiting at 1 site No phase Knee Osteoarthritis

Trial comparing treatments for Knee Osteoarthritis

Official title Mechanical Alignment vs Kalipered Kinematic Alignment Total Knee Arthroplasty

ClinicalTrials.gov ID: NCT06617871

What this study is testing

What it's testing
The study wants to see if the new alignment method (Kinematic Alignment) gives better results than the traditional method (Mechanical Alignment).
Who it's for
Adults who have knee osteoarthritis and are scheduled for knee replacement surgery.
What's involved
Participants will receive one of the two surgical techniques. They will have the same follow‑up visits and tests as usual after surgery.
Time commitment
The study lasts until the final follow‑up visit, typically several months after surgery, with a few scheduled clinic visits during that time.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 79

You may be able to join if

  • Patient undergoing primary TKA with a medially-stabilized SpheriKA knee system
  • Able to read and understand consent form and PRO instruments and willing to return for follow up visits

You likely can't join if

  • Varus or Valgus malalignment \>15 degrees to mechanical axis
  • Flexion contracture \>15 degrees or flexion \<90 degrees
  • BMI \>40
  • Revision TKA or other prior knee surgery other than arthroscopy or arthroscopic-assisted ligament reconstruction
  • Diagnosis or history of any of the following
  • inflammatory arthritis
See the full eligibility criteria
Who can join
  • Patient undergoing primary TKA with a medially-stabilized SpheriKA knee system
  • Able to read and understand consent form and PRO instruments and willing to return for follow up visits
What rules you out
  • Varus or Valgus malalignment \>15 degrees to mechanical axis
  • Flexion contracture \>15 degrees or flexion \<90 degrees
  • BMI \>40
  • Revision TKA or other prior knee surgery other than arthroscopy or arthroscopic-assisted ligament reconstruction
  • Diagnosis or history of any of the following
  • inflammatory arthritis
  • infection in study knee
  • chronic pain
  • chronic opioid use
  • metabolic musculoskeletal disorder other than osteopenia/osteoporosis
  • Patients receiving workers' compensation for study condition
  • Patients who cannot complete questionnaires in English
  • Patients with comorbidities preventing surgery
  • Patients who are not able to provide informed consent

The study team makes the final eligibility decision.

Where it is enrolling

  • Chicago, Illinois, United States

Compensation & support

This study's listing mentions compensation or reimbursement.

No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 79 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.